Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

$45M awarded to develop sense-and-respond implant technology for cancer treatment

The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more than 50%.

26 Sep 2023

Key player in ovarian cancer may have implications for PCOS

Researchers explore the involvement and altered expression of BBOX1-AS1 and microRNA-19b in polycystic ovary syndrome.

26 Sep 2023

Everyday chemicals linked to increased cancer risk, especially in women

This study identifies links between exposure to chemicals like PFAS, parabens, and phenols and increased cancer risk, particularly among women and across racial groups. The findings spotlight the role of environmental toxins in hormone-related cancers, suggesting new avenues for cancer prevention and mitigation strategies.

24 Sep 2023

Clinical trial hopes to enhance treatment options for women with lethal gynecological cancers

An international clinical trial exploring a new way to treat rare and aggressive gynaecological cancers has launched in Melbourne.

21 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.

21 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences-;primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI)-;remain vitally important to improving health and saving lives.

13 Sep 2023

Study reveals potential negative long-term effects of premenopausal bilateral oophorectomy

Increasing concerns regarding potentially harmful long-term effects of premenopausal bilateral oophorectomy (PBO) have caused a decline in the number of women choosing to proactively remove both ovaries as a precaution to protect against ovarian cancer.

13 Sep 2023

Research shines light on early life factors that may increase risk of cardiovascular disease in women

Advanced research is casting light on possible early life factors – including poverty, physical or mental abuse – that may impact the rate of egg loss and increase the risk of cardiovascular disease in post-menopausal women.

9 Sep 2023

Myriad Genetics survey: Women have widespread confusion and misconceptions about ovarian cancer screening

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women.

7 Sep 2023

Study identifies potential target for reversing drug resistance in ovarian cancer

For the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin.

5 Sep 2023

Early onset cancers exacting heaviest toll on young adults over the past three decades

There's been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990-2019), finds research published today in the open access journal BMJ Oncology.

5 Sep 2023

Swedish study changes national guidelines for genetic testing in breast cancer

BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of hereditary breast and ovarian cancer. However, there are an additional eleven genes associated with elevated risk for these types of cancer.

23 Aug 2023

Ovarian cancer patients enrolled in first-in-human trial of CAR T cell therapy

Recently published preclinical data by City of Hope scientists shows the immunotherapy is effective. Advanced ovarian cancer patients are now being enrolled in a Phase 1 first-in-human trial.

10 Aug 2023

Identification of plasma proteins associated with ovarian cancer risk

Researchers performed proteomic Mendelian randomization as well as co-localization analyses to identify drug targets for ovarian cancer.

8 Aug 2023

CAR-T immune therapies could be effective against solid tumors

CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests.

3 Aug 2023

UCSF Medical Center named to Honor Roll of nation's top hospitals

U.S. News & World Report ranks UCSF Health adult care among nation's top 10 hospitals in 7 specialties, Best in the West for neurology/neurosurgery and rheumatology.

1 Aug 2023

IN8bio opens new cancer research lab in Birmingham's Pepper Place

Birmingham's Pepper Place has a striking new addition to its teeming farmers' market and noted food offerings -; a multimillion-dollar cancer research laboratory.

1 Aug 2023

Black women weigh emerging risks of ‘creamy crack’ hair straighteners

Deanna Denham Hughes was stunned when she was diagnosed with ovarian cancer last year. She was only 32. She had no family history of cancer, and tests found no genetic link. Hughes wondered why she, an otherwise healthy Black mother of two, would develop a malignancy known as a "silent killer."

1 Aug 2023

New class of antibody could benefit patients with treatment-resistant cancers

A Cancer Research UK-funded clinical trial has shown, for the first time, that a new class of antibody could benefit cancer patients whose existing treatments have stopped working.

28 Jul 2023

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

$45M awarded to develop sense-and-respond implant technology for cancer treatment

Key player in ovarian cancer may have implications for PCOS

Everyday chemicals linked to increased cancer risk, especially in women

Clinical trial hopes to enhance treatment options for women with lethal gynecological cancers

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Study reveals potential negative long-term effects of premenopausal bilateral oophorectomy

Research shines light on early life factors that may increase risk of cardiovascular disease in women

Myriad Genetics survey: Women have widespread confusion and misconceptions about ovarian cancer screening

Study identifies potential target for reversing drug resistance in ovarian cancer

Early onset cancers exacting heaviest toll on young adults over the past three decades

Swedish study changes national guidelines for genetic testing in breast cancer

Ovarian cancer patients enrolled in first-in-human trial of CAR T cell therapy

Identification of plasma proteins associated with ovarian cancer risk

CAR-T immune therapies could be effective against solid tumors

UCSF Medical Center named to Honor Roll of nation's top hospitals

IN8bio opens new cancer research lab in Birmingham's Pepper Place

Black women weigh emerging risks of ‘creamy crack’ hair straighteners

New class of antibody could benefit patients with treatment-resistant cancers

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in